Download pdf - CURRICULUM VITAE - mcgill.ca · clinical innovation” (with James Allen Evans, Jean-Philippe Cointet, Peter Keating and Pascale Bourret). • 2015-2016 – [co-PI]

CURRICULUM VITAE

Alberto Cambrosio, Ph.D. November 2017

Date of birth: December 8, 1950

Place of birth: Lugano (Switzerland) Citizenship: Swiss and Canadian Languages: French, English, Italian (write and speak)

German, Spanish (read) Address (Work): Department of Social Studies of Medicine

McGill University 3647 Peel Street Montreal, Quebec H3A 1X1 Tel.: ++1-514 398-4981 Fax: ++1-514 398-1498 E-Mail: [email protected] Web: http://www.mcgill.ca/ssom/staff/alberto-cambrosio

Education 1977-1984: Philosophiae Doctor - “Histoire et Sociopolitique des Sciences” (History and

Sociology of Science), University of Montreal (Quebec, Canada) [12 January 1984]

1975-1977: Maîtrise en Environnement (Master’s Degree in Environmental Sciences), Faculty of Science, University of Sherbrooke (Quebec, Canada) [22 October 1977]

1969-1974: Diplom (B.Sc. Honours) - Zoology (Biology), Faculty of Science, University of Basel (Switzerland) [10 December 1973]

Alberto Cambrosio, Curriculum Vitae – page 2

Fields of specialization

Sociology of science, technology and medicine Sociology of biomedical knowledge and practices Sociology of innovation History of contemporary biomedicine Social assessment of science and technology

Academic and professional experience PRESENT POSITION

Since 1990: Department of Social Studies of Medicine (also: Associate Member, Department of Sociology), McGill University (Montreal): • 2004 (June) – present: Full Professor • 1994 (June) – 2004: Associate Professor (with tenure) • 1990 - 1994: Associate Professor (tenure track)

PREVIOUS AND TEMPORARY POSITIONS

• 2005-2016: Chair, Department of Social Studies of Medicine, McGill University. • 2016 (June): Invited Researcher, Making Genomic Medicine project, Science, Technology

and Innovation Studies Subject Group, University of Edinburgh (UK). • 2009-2015: “Mentor”, The Health Care, Technology, and Place II (HCTP2) CIHR Strategic

Research and Training Program. • 2011-2012: Invited Researcher, Centre de Sociologie des Organisations, Sciences Po,

Paris. • 2009 (June-July): Invited Researcher, UMR 912 Inserm-IRD-Université de la Méditerranée

(SE4S: “Sciences Economiques et Sociales, Systèmes de Santé, Sociétés”), Marseille (France).

• 2008 (May-June): Invited Researcher, UMR 912 Inserm-IRD-Université de la Méditerranée (SE4S: “Sciences Economiques et Sociales, Systèmes de Santé, Sociétés”), Marseille (France).

• 2007-2008: “Mentor”, The Health Care, Technology, and Place (HCTP) CIHR Strategic Research and Training Program.

• 1991-2008: Regular member, Centre interuniversitaire de recherche sur la science et la technologie (CIRST), Montreal.

• 2007 (May-June): Invited Professor (“Professeur associé de 1ère classe”), École Nationale Supérieure des Mines de Paris, Centre de Sociologie de l’Innovation.

• 2005 (April): Visiting Fellow, ESRC Centre for Social and Economic Aspects of Genomics (CESAGen), Cardiff School of Social Sciences, University of Cardiff (UK).

• 2004-2005 (September-May): Senior Invited Researcher, Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 502: Centre de Recherche Médecine, Sciences, Santé et Société (CERMES), Villejuif (Paris, France).


• 2002 (January–August): Acting Chair, Department of Social Studies of Medicine, McGill University.

• 2001 (January-December): Senior Invited Researcher (“Poste orange”), Institut National de la Santé et de la Recherche Médicale (INSERM), Unit 379: Épidémiologie et sciences sociales appliquées à l’innovation médicale, Institut Paoli-Calmettes, Marseilles (France).

• 1999 (October-November): Invited Visiting Scholar, Max-Planck Institute for the History of Science, Berlin, Germany.

• 1999 (March-June): Invited Research Fellow, Wellcome Institute for the History of Medicine, History of Modern Biomedical Science Unit, London (U.K.)

• 1997 (February-March): Invited Professor, Faculté de Lettres et Philosophie, Université de Bourgogne, Dijon (France).

• 1996-1997: Invited researcher, Centre de Sociologie de l’Innovation, École Nationale Supérieure des Mines, Paris, and INSERM Unité 158 “Savoirs et pratiques dans le champ médical: histoire, sociologie, psychanalyse”, Hôpital des Enfants Malades, Paris.

• 1986-1990: “Professeur sous octroi” (Research Professor), Centre de recherche en évaluation sociale des technologies (CREST), and Department of Sociology, Université du Québec à Montréal.

• 1990 (July-September): “Maître de recherche associé” (Research Associate), Centre de Sociologie de l’Innovation, École Nationale Supérieure des Mines, Paris.

• 1985-1986: Visiting Scholar (Postdoctoral Fellow), Program in Science, Technology, and Society, Massachusetts Institute of Technology.

• 1984-1985: Postdoctoral Fellow, Department of Sociology, Université de Montréal. • 1984: Postdoctoral Fellow, Department of Sociology, Université du Québec à Montréal. • 1983-1984: Consulting Professor, Télé-Université (Université du Québec). • 1983: Research Assistant, Institut Québécois de Recherches sur la Culture. • 1980-1983: Lecturer, Department of Biological Sciences, Université du Québec à

Montréal. • 1978-1980: Teaching Assistant, École Polytechnique de Montréal. • 1978: Research Assistant, Institut d’Histoire et de Sociopolitique des Sciences, Université

de Montréal.

Honors and awards

• 2011-2012: Senior Fellow of the “Research in Paris” program, City of Paris. • 2009-2010: Gordon Cain Fellow in Technology, Policy, and Entrepreneurship, Chemical

Heritage Foundation, Philadelphia. • 2005: Ludwik Fleck Prize by the Society for Social Studies of Science (4S) for the book

Biomedical Platforms, co-authored with Peter Keating. The Prize is awarded annually for the best book in the area of science and technology studies.

• 1997: Burroughs Wellcome Fund, 40th Anniversary Award in the History of Medicine. • 2005-present: Member of the Editorial Advisory Board of Social Studies of Science. • 1998-present: Member of the International Editorial Advisory Board of New Genetics &

Society. • 2007-present: Member of the Editorial Board of History and Philosophy of the Life

Sciences. • 1997-2000: Member of the Advisory Editorial Board of Social Problems.


Research grants and contracts • 2016-2019 – [Collaborator] Network of Centres of Excellence, BioCanRx Clinical, Social

and Economic Impact Program: “Towards Rational Design of Policies and Practices to Enable Clinical Translation of Novel Cancer Biotherapeutics in Canada” (with Tania Bubela, PI, Co-PIs: Christopher McCabe, Jean Sébastien Delisle; Collaborators: Harold Atkins, Jonathan Kimmelman, Richard Gold, Robert Holt, Katherine Bonter, Sowmya Viswanathan, Robert Cook-Degan, David Evans, Katerina Maxikova).

• 2015-2019 – [PI] Canadian Institutes of Health Research Grant (MOP-142478): “Oncology's metaknowledge networks: an investigation of the collective dynamics of bio-clinical innovation” (with James Allen Evans, Jean-Philippe Cointet, Peter Keating and Pascale Bourret).

• 2015-2016 – [co-PI] Portuguese Association for Cancer Research and Fundação Calouste Gulbenkian: “CancerRePort / RePortCancer: Researching the dynamics and international positioning of the Portuguese medical oncology community” (with Leonor David, PI, and João Arriscado Nunes and Jean-Philippe Cointet, co-PIs).

• 2014-2017 – [Co_PI] Institut National du Cancer (INCa) Grant (France; SHSESP14-002): “Les thérapies ciblées à l'essai: une exploration sociologique de la médecine personnalisée en action” (with Pascale Bourret PI, Patrick Castel and Henri Bergeron).

• 2014-2018 – [PI] Canadian Institutes of Health Research Grant (MOP-133687): “Genomic medicine enters the clinic: translational research, actionable mutations, clinical utility, and the reframing of oncology” (with Peter Keating and Nicole Nelson).

• 2013-2015 – [Collaborator] Institut National du Cancer (INCa) Grant (France; “subvention de recherche hors appel à projet”): “Analyse qualitative des SIRIC (Sites de Recherche Intégrée sur le Cancer)” (with Patrick Castel PI, Henri Bergeron).

• 2012-2016 – [PI] Fonds FRQSC Grant SE-164195 “Production et globalisation des savoirs et des pratiques dans le domaine biomédical: une approche interdisciplinaire et comparative” (with Peter Keating, Tobias Rees, Thomas Schlich, and George Weisz).

• 2011-2014 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-2011-2290: “Risk and Technology: A History of Pathology’s New Style of Practice (1975-1996)” (with Peter Keating).

• 2010-2013 – [Co-PI] Genome Québec: “Molecular profiling of drug resistant triple negative breast cancer” (GE3LS component of a grant with Mark Basik, Gerald Batist, Peter Keating, Jonathan Kimmelman and Jacek Majewski).

• 2009-2015 – [Collaborator] Canadian Institutes of Health Research Grant (Strategic Training Initiative in Health Research program): “Health Care, Technology & Place (HCTP): A CIHR Strategic Training Initiative” (PI: Peter C. Coyte; 21 co-PIs).

• 2009-2013 – [PI] Canadian Institutes of Health Research Grant (MOP-93553): “From Oncogenes to Genomic Medicine: A Social and Historical Analysis of Translational Cancer Research” (with Peter Keating).

• 2008-2012 – [PI] Fonds FQRSC Grant SE-124896 “Production des savoirs et hétérogénéité des pratiques dans le domaine biomédical: une approche comparative” (with Peter Keating, Thomas Schlich and George Weisz).

• 2008-2011 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-2008-1833: “From Oncogenes to Post-Genomic Medicine: How Molecular Biology Transformed Clinical Cancer Research (1975-2000)” (with Peter Keating).


• 2007-2009 – [Co-PI] 61e Commission permanente de coopération franco-québécoise, “Étude interdisciplinaire de l'impact du contexte culturel et organisationnel sur les décisions et standards de pratique en cancérologie” (with Jean Latreille, Louise Paquet, Raghu Rajan, Loes Knaapen, Béatrice Fervers, Magali Remy-Stockinger, Anne Bataillard, Hervé Cazeneuve and Patrick Castel).

• 2007 – [Co-PI] Social Sciences and Humanities Research Council of Canada, Aid to Research Workshops and Conferences Grant 646-2006-1083: “The institutions of objectivity in medicine: Informal and formal modalities of regulation” (with Thomas Schlich, George Weisz and Peter Keating).

• 2006-2011 – [Collaborator] Institut National du Cancer (INCa) Grant (France; Processus et perspectives de développements de la recherche clinique en cancérologie): “Traitements ciblés sur une signature génomique en oncologie: itinéraire d’un essai et enjeux pour les patients” (with Claire Julian-Reynier PI, Isabelle Pellegrini; Pascale Bourret; Themis Apostolidis).

• 2005-2008 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-2005-1350: “Clinical Cancer Research, 1950-2000: The Emergence and Development of a New Science” (with Peter Keating).

• 2004-2008 – [PI] Fonds FQRSC Grant SE-95786 “Production des savoirs et hétérogénéité des pratiques dans le domaine biomédical: une approche comparative” (with Peter Keating, Thomas Schlich and George Weisz).

• 2004-2005 – [PI] Canadian Institutes of Health Research, International Scientific Exchange Award (CIHR/INSERM Agreement): “Les institutions de l'objectivité médicale: Le développement de la recherche clinique sur le cancer en Europe”.

• 2003-2008 – [Co-PI] Canadian Institutes of Health Research Grant (MOP-64372): “Managing Differences: The Institutions of Medical Objectivity, 1945-2000” (with George Weisz, Thomas Schlich, Rebecca Fuhrer and Peter Keating).

• 2002-2005 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-2002-1453: “Towards a History of ‘Biomedicine’: The Post-war Realignment of Biology and Clinical Medicine” (with Peter Keating).

• 2002-2008 – [Co-PI] Fonds FQRSC Research Center Grant 79110, “Centre interuniversitaire de recherche sur la science et la technologie (CIRST)” (with 27 other researchers from UQAM, UQTR, University of Montreal, University of Sherbrooke, University of Ottawa, Télé-Université and INRS-Urbanisation).

• 2000-2004 – [PI] Fonds FCAR (FQRSC) Grant 01-ER-70743: “Innovations technoscientifiques, recherches biomédicales et interventions cliniques: la régulation des pratiques biomédicales” (with Peter Keating).

• 1998-2001 – [Co-PI] Fonds FCAR Research Center Grant, “Centre interuniversitaire de recherche sur la science et la technologie (CIRST)” (with 12 other researchers from UQAM, University of Montreal, University of Sherbrooke and INRS-Urbanisation).

• 1997-2001 – [PI] Burroughs Wellcome Fund, 40th Anniversary Award in the History of Medicine: “New Biomedical Technologies and the Transformation of Hematology and Clinical Immunology (1960-Present)”.

• 1997-2000 – [PI] Fonds FCAR Grant 98-ER-2220: “Innovations technoscientifiques, recherche biomédicale et interventions cliniques: à propos de la régulation du travail médical” (with Peter Keating).

• 1997-2000 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-97-0689: “Scientific Instrumentalities and the Transformation of Medical Judgment after World War II” (with Peter Keating).


• 1999 – [PI] Burroughs Wellcome Fund, Wellcome Research Travel Grant for a 3-month visit to The Wellcome Institute for the History of Medicine (London, U.K.).

• 1994-1997 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-94-0352: “Standards, Instruments and Techniques in the Biological and Biomedical Sciences: A Comparative Approach, 1945-1990” (with Peter Keating and Camille Limoges).

• 1994-1997– [Co-PI] Social Sciences and Humanities Research Council of Canada Strategic Grant 809-94-008: “L’expertise dans les sciences du risque en contexte de controverse technologique” (with Camille Limoges). Matching contribution from the Conseil de la Science et de la Technologie du Québec.

• 1994-1997 – [PI] Fonds FCAR Grant 95-ER-2220: “Pour une sociologie des pratiques biomédicales: instruments et techniques de visualisation” (with Peter Keating).

• 1994-1997 – [PI] Hannah Institute for the History of Medicine Grant-in-Aid: “The Development of Immunological Imagery, 1900-1980” (with Peter Keating).

• 1991-1994 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-91-1935: “The technological shaping of the life sciences after World War II: A research program” (with Camille Limoges and Peter Keating).

• 1991-1994 – [Co-PI] Social Sciences and Humanities Research Council of Canada Strategic Grant 809-91-0013: “La gestion publique des technologies controversées” (with Camille Limoges).

• 1991-1994 – [Co-PI] Fonds FCAR Grant 92-ER-1204: “L’évaluation sociale des technologies: production, diffusion et appropriation des nouvelles technologies et des savoirs scientifiques et technologiques” (with Céline Saint-Pierre, Eric Alsène, Paul Carle, Pierre Doray, Camille Limoges and Bernard Schiele).

• 1990-1991 – [PI] McGill Social Sciences Research Grants Office: “The technological shaping of immunology after World War II: A case study of flow cytometry”.

• 1989-1991 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-89-1405: “Biological safety: Its history as a profession and as a discipline” (with Camille Limoges).

• 1989-1991 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-89-1167: “L’émergence de normes: l’AZT, médicament contre le SIDA” (with Ruth Murbach).

• 1989-1991 – [Co-PI] Grant from the “Coopération franco-québécoise en enseignement supérieur et recherche”: “Le développement des biotechnologies: Analyse intégrée de ses aspects socio-politiques et de leurs incidences économiques” (with Camille Limoges, and researchers of the Centre de Sociologie de l’Innovation, Ecole Nationale Supérieure des Mines, Paris).

• 1988-1991 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-88-0637: “Technologies de l’information, travail et qualifications: une comparaison entre l’industrie manufacturière et les services” (with Céline Saint-Pierre and Pierre Doray).

• 1988-1991 – [Co-PI] Fonds FCAR Grant 89-EQ-3517: “Technologies de l’information, travail et qualifications: une comparaison entre l’industrie manufacturière et les services” (with Céline Saint-Pierre et Pierre Doray).

• 1988-1990 – [Co-PI] Fonds FCAR Grant 89-AS-2674: “L’émergence de normes: le cas du Zidovudine, médicament contre le SIDA” (with Ruth Murbach).

• 1988-1989 – [PI] PAFACC (UQAM): “L’émergence et la diffusion des anticorps monoclonaux: analyse de la littérature scientifique par ordinateur (méthode Leximappe)”.


• 1988-1989 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-88-1038: “L’émergence de normes: le cas du Zidovudine, médicament contre le SIDA” (with Ruth Murbach).

• 1988-1990 – [Co-PI] Grant from the “Coopération franco-québécoise en enseignement supérieur et recherche”: “Maîtrise sociale des technologies: informatisation du travail” (with Céline Saint-Pierre and Pierre Doray, and researchers of the Centre de recherche en Economie des Changements Technologiques, Université de Lyon II).

• 1988-1990 – [Co-PI] Contract from the Centre Québécois de Valorisation de la Biomasse: “Description analytique du déroulement et de la dynamique des controverses sur la biosécurité” (with Camille Limoges).

• 1987-1989 - [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 499-87-0020: “Informatique, travail et services de santé: études de cas” (with Céline Saint-Pierre and Denise Couture).

• 1986-1988 – [Co-PI] Social Sciences and Humanities Research Council of Canada Grant 410-86-0341: “Sociologie d’une innovation biomédicale: la technologie des hybridomes” (with Peter Keating and Michael Mackenzie).

• 1986-1988 – [Co-PI] PAFACC (UQAM): “Qualifications, savoirs et nouvelles technologies dans le secteur tertiaire” (with Céline Saint-Pierre).

• 1986-1987 – [Co-PI] Contract from the Canadian Workplace Automation Research Center: “Changement de la nature des tâches et intégration de la bureautique” (with Céline Saint-Pierre).

• 1984-1985 – [Co-PI] Fonds FCAC Grant 85-AR-0262: “Vers un modèle socio-économique intégré de la production de l’innovation biotechnologique” (with Peter Keating and Michael Mackenzie).

Publications BOOKS

• Peter Keating and Alberto Cambrosio, Cancer on Trial: Oncology as a New Style of

Practice. Chicago: The University of Chicago Press, 2012; xviii, 456 p. Paperback edition: 2014.

Reviews: R.M. Kluchin, American Historical Review 118 (2013), 166-7; S. Pemberton, “Biomedicine writ small: The self-vindication of cooperative clinical trials,” Metascience 22 (2013), 405–408; R.W. Scheffler, Medical History 57 (2013), 450-452; C.M. Murray, “Tracing biomedical dispositifs: Play, rigor, and cooperation in medical oncology,” Social Studies of Science 43 (2013), 792-797; C. Timmermann, Isis 104 (2013), 649-650; N. Eschenbruch, Gesnerus 69 (2012), 359-361; S. Mwale, Sociology of Health & Illness 36 (2014), 787-788; P. Castel, “Les dimensions organisationnelles de la biomédecine,” Sciences Sociales et Santé 32(3) (2014), 99-107; The Lamp 71(10) (2014), 45; S. Crabu Tecnoscienza 5(2) (2014), 98-103; G. Kutcher, Journal of the History of Medicine and Allied Sciences (2015), doi:10.1093/jhmas/jrv027.


• Peter Keating and Alberto Cambrosio, Biomedical Platforms. Realigning the Normal and

the Pathological in Late-Twentieth-Century Medicine. Cambridge, MA: MIT Press, 2003; xiv, 544 p. Paperback edition: 2006.

Reviews: S.H. Podolsky, Journal of the History of Medicine and Allied Sciences 59 (2004), 602-4; P.M.H. Mazumdar, New England Journal of Medicine 351(25) (2004), 2664-5; M.G. Golightly, Quarterly Review of Biology 79(3) (2004), 343; I. Löwy, Bulletin of the History of Medicine 79 (2005), 373-3; D.B. Paul, Isis 96 (2005), 146-7; G. Madhavan, IEEE Engineering in Medicine and Biology Magazine 24(3) (2005), 19; H. Pols, Minerva 43 (2005), 331-4; C. Lawrence, Medical History 50 (2006), 125-7. Focus of an “Author Meets Critics” session at the annual meeting of the Society for Social Studies of Science, 2005. Recipient, Ludwik Fleck Prize, Society for Social Studies of Science, 2005.

• Alberto Cambrosio and Peter Keating, Exquisite Specificity. The Monoclonal Antibody Revolution. New York: Oxford University Press, 1995; xv, 243 p.

Reviews: S. Hilgartner, Science 274 (1996), 934-35; F.S. Rosen, Nature 383 (1996), 777; Canadian Journal of Allergy and Clinical Immunology 1(5) (1996); N. Rasmussen, Historical Studies in the Physical and Biological Sciences 27 (1996), 178-79; L.E. Kay, Bulletin of the History of Medicine 71 (1997), 566-67; D.L. French, Quarterly Review of Biology 72 (1997), 238; P.M.H. Mazumdar, Isis 89 (1998), 574-75; T. Söderqvist and C. Stillwell, Journal of the History of Biology 32 (1999), 205-15.

EDITED WORKS: BOOKS

• Anne Marie Moulin and Alberto Cambrosio (Eds), Singular Selves. Historical Issues and Contemporary Debates in Immunology. Paris: Elsevier, 2001; 303 p.

Reviews: M.J. Stone, Canadian Bulletin of Medical History 19 (2002), 504-6; P.M.H. Mazumdar, British Journal for the History of Science 37 (2004), 486-7.

• Margaret Lock, Allan Young and Alberto Cambrosio (Eds), Living and Working with the New Medical Technologies. Intersections of Inquiry. Cambridge: Cambridge University Press, 2000; ix, 295 p.

Reviews: A. Abdul-Fadl, Social Science & Medicine 55 (2002), 1077-8; P. Brodwin, Medical Anthropology Quarterly 15 (2001), 412-3; A. Dittmar, Anthropos 97 (2002), 273-4; C.R. Barber, Journal of Medical Ethics 28 (2002), 60-1; L. Prior, Sociology of Health and Illness 23 (2001), 251-2; Michael M.J. Fischer, American Anthropologist 106 (2004), 389-91.


• Alberto Cambrosio and Raymond Duchesne (Eds), Science, Technologie et Société: Les

enjeux du progrès. Québec: Presses de l’Université du Québec, 1984, 356 p.

EDITED WORKS: SPECIAL ISSUES

• Alberto Cambrosio, Peter Keating, Thomas Schlich and George Weisz (Eds), Biomedical Conventions and Regulatory Objectivity. Social Studies of Science Vol. 39(5), October 2009.

• Peter Keating, Miriam Balaban, Alberto Cambrosio and Alfred I. Tauber (Eds), Historical Studies on Immunology. Journal of the History of Biology Vol. 30(3), Fall 1997.

• Alberto Cambrosio, Peter Keating and Alfred I. Tauber (Eds), Immunology as a Historical Object. Journal of the History of Biology Vol. 27(3), Fall 1994.

ARTICLES IN REFEREED JOURNALS

• A70—Alberto Cambrosio, Peter Keating, Pascale Bourret, Étienne Vignola-Gagné, and Sylvain Besle, “Extending Experimentation: Oncology’s Fading Boundary Between Research and Care.” Submitted.

• A60—Oriana Rainho Brás, Jean-Philippe Cointet, Alberto Cambrosio, Leonor David, João Arriscado Nunes, Fátima Cardoso, and Carmen Jerónimo, “Oncology Research in Late 20th Century and Turn of the Century Portugal. A Scientometric Approach to its Institutional and Semantic Dimensions.” Scientometrics,113 (2017), 867–888.

• A68—George Weisz, Alberto Cambrosio and Jean-Philippe Cointet, “Mapping Global Health: A Network Analysis of a Heterogeneous Publication Domain.” BioSocieties. doi:10.1057/s41292-017-0053-4.

• A67—Alberto Cambrosio, Pascale Bourret, Peter Keating and Nicole Nelson, “Opening the Regulatory Black Box of Clinical Cancer Research: Transnational Expertise Networks and ‘Disruptive’ Technologies.” Minerva, 55(2) (2017), 161-185.

• A66—Étienne Vignola-Gagné, Peter Keating and Alberto Cambrosio, “Informing Materials: Drugs as Tools for Exploring Cancer Mechanisms and Pathways.” History and Philosophy of the Life Sciences (2017) 39:10. doi:10.1007/s40656-017-0135-4.

• A65—Peter Keating, Alberto Cambrosio and Nicole Nelson “’Triple Negative Breast Cancer’: Translational Research and the (Re)Assembling of Diseases in Post-Genomic Medicine.” Studies in History and Philosophy of Biological and Biomedical Sciences, 59 (2016), 20-34.

• A64—Alberto Cambrosio, Peter Keating and Nicole Nelson, “Régimes thérapeutiques et dispositifs de preuve en oncologie: l’organisation des essais cliniques des groupes coopérateurs aux consortiums de recherche.” Sciences Sociales et Santé, 32(3) (2014), 13-42.

• A63—Alberto Cambrosio, Pascale Bourret, Vololona Rabeharisoa and Michel Callon, “Big Data and the Collective Turn in Biomedicine: How Should We Analyze Post-Genomic Practices?” Tecnoscienza, 5(1) (2014), 13-44.


• A62—Nicole Nelson, Peter Keating, Alberto Cambrosio, Adriana Aguilar-Mahecha and Mark Basik, “Testing Devices or Experimental Systems? Cancer Clinical Trials Take the Genomic Turn.” Social Science & Medicine, 111 (2014), 74-83.

• A61—Nicole Nelson, Peter Keating and Alberto Cambrosio, “On Being ‘Actionable’: Clinical Sequencing and the Emerging Contours of a Regime of Genomic Medicine in Oncology.” New Genetics & Society, 32 (2013), 405-428.

• A60—Peter Keating and Alberto Cambrosio, “21st Century Oncology: A Tangled Web.” Lancet, 382 (December 14, 2013), e45-e46.

• A59—Christopher Canning, George Weisz, Andrea Tone and Alberto Cambrosio, “Medical Genetics at McGill: The History of a Pioneering Research Group.” Canadian Bulletin of Medical History, 30 (2013), 31-54.

• A58— Peter Keating, Alberto Cambrosio, Nicole Nelson, Andrei Mogoutov and Jean-Philippe Cointet, “Therapy’s shadow: a short history of the study of resistance to cancer chemotherapy.” Frontiers in Pharmacology (special issue on “Therapeutic Resistance in Cancer: Mechanisms, Insights and Progress”), 2013, 4:58.

• A57—Jean-Philippe Cointet, Andrei Mogoutov, Pascale Bourret, Rym El-Abed and Alberto Cambrosio, “Les réseaux de l’expression génique : émergence et développement d’un domaine clé de la génomique.” Médecine/Sciences, 28 (Hors série 1) (2012), 7-13.

• A56—Peter Keating and Alberto Cambrosio, “Too Many Numbers: Microarrays in Clinical Cancer Research.” Studies in History and Philosophy of Biological and Biomedical Sciences, 43 (2012), 37-51.

• A55—Peter Keating and Alberto Cambrosio, “Clinical Trials in the Age of Personalized Medicine.” Journal of Medicine and the Person, 9 (2011), 91-98.

• A54—Pascale Bourret, Peter Keating and Alberto Cambrosio, “Regulating Diagnosis in Post-Genomic Medicine: Re-Aligning Clinical Judgment?” Social Science & Medicine, 73 (2011), 816-824.

• A53—David Jones, Alberto Cambrosio and Andrei Mogoutov, “Detection and Characterization of Translational Research in Cancer and Cardiovascular Medicine.” Journal of Translational Medicine, 2011, 9:57 (12 pages).

• A52—Nina Kohli-Laven, Pascale Bourret, Peter Keating and Alberto Cambrosio, “Cancer Clinical Trials in the Era of Genomic Signatures: Biomedical Innovation, Clinical Utility, and Regulatory-Scientific Hybrids.” Social Studies of Science, 41 (2011), 487-513.

• A51—Loes Knaapen, Hervé Cazeneuve, Alberto Cambrosio, Patrick Castel and Béatrice Fervers, “Pragmatic Evidence and Textual Arrangements: A Case Study of French Clinical Cancer Guidelines.” Social Science & Medicine, 71 (2010), 685-692.

• A50—Peter Keating and Alberto Cambrosio, “Who’s Minding the Data? Data Managers and Data Monitoring Committees in Clinical Trials.” Sociology of Health & Illness, 31 (2009), 325-342.

• A49—Andrei Mogoutov, Alberto Cambrosio, Peter Keating and Philippe Mustar, “Biomedical Innovation at the Laboratory, Clinical and Commercial Interface: A New Method for Mapping Research Projects, Publications and Patents in the Field of Microarrays.” Journal of Informetrics, 2 (2008), 341-353.

• A48—Alberto Cambrosio, Daniel Jacobi and Peter Keating, “Phages, Antibodies and De-Monstration.” History and Philosophy of the Life Sciences, 30 (2008), 131-158.

• A47—Susan Rogers and Alberto Cambrosio, “Making a New Technology Work: The Standardization and Regulation of Microarrays.” Yale Journal of Biology and Medicine, 80 (2007), 165-178.


• A46—George Weisz, Alberto Cambrosio, Peter Keating, Loes Knaapen, Thomas Schlich and Virginie Tournay, “The Emergence of Clinical Practice Guidelines.” The Milbank Quarterly, 85 (2007), 691-727.

• A45—Peter Keating and Alberto Cambrosio, “Cancer Clinical Trials: The Emergence and Development of a New Style of Practice.” Bulletin of the History of Medicine (Special Issue on the History of Cancer), 81 (2007), 197-223.

• A44—Alberto Cambrosio, Peter Keating and Pascale Bourret, “Objectividad regulatoria y sistemas de pruebas en medicina: El caso de la cancerología.” Convergencia, 42 (2006), 135-152. [Spanish version of BC25]

• A43—Alberto Cambrosio, Peter Keating, Simon Mercier, Grant Lewison, and Andrei Mogoutov, “Mapping the Emergence and Development of Translational Cancer Research.” European Journal of Cancer, 42 (2006), 3140-3148.

• A42—Pascale Bourret, Andrei Mogoutov, Claire Julian-Reynier and Alberto Cambrosio, “A New Clinical Collective for French Cancer Genetics: A Heterogeneous Mapping Analysis.” Science, Technology, & Human Values, 31 (2006), 431-464.

• A41—Alberto Cambrosio, Peter Keating, Thomas Schlich and George Weisz, “Regulatory Objectivity and the Generation and Management of Evidence in Medicine.” Social Science & Medicine, 63 (2006), 189-199.

• A40—Alberto Cambrosio, “Rationalisation et médecine des preuves en oncologie: quelques remarques à propos de la régulation des pratiques biomédicales.” Sciences Sociales et Santé, 23(4) (2005), 41-48.

• A39—Alberto Cambrosio, Daniel Jacobi and Peter Keating, “Intertextualité et archi-iconicité. Le cas des représentations scientifiques de la réaction antigène-anticorps.” Études de communication, 27 (Special issue: Analyse communicationnelle et épistémologie des sciences sociales) (2005), 75-93.

• A38—Alberto Cambrosio, Daniel Jacobi and Peter Keating, “Arguing with Images: Pauling’s Theory of Antibody Formation.” Representations, 89 (2005), 94-130.

• A37—Peter Keating and Alberto Cambrosio, “Does Biomedicine Entail the Successful Reduction of Pathology to Biology?” Perspectives in Biology and Medicine, 47 (2004), 357-371.

• A36—Alberto Cambrosio, Peter Keating and Andrei Mogoutov, “Mapping Collaborative Work and Innovation in Biomedicine: A Computer-Assisted Analysis of Antibody Reagent Workshops.” Social Studies of Science, 34 (2004), 325-364.

• A35—Peter Keating and Alberto Cambrosio, “Signs, Markers, Profiles, and Signatures: Clinical Hematology Meets the New Genetics (1980-2000).” New Genetics and Society, 23 (2004), 15-45.

• A34—Alberto Cambrosio and Peter Keating, “Qu’est-ce que la biomédecine? Repères socio-historiques.” Médecine/Sciences, 19 (2003), 1280-1287.

• A33—Peter Keating and Alberto Cambrosio, “Beyond ‘Bad News’: The Diagnosis, Prognosis and Classification of Lymphomas and Lymphoma Patients in the Era of Biomedicine (1945-1995).” Medical History, 47 (2003), 291-312.

• A32—Peter Keating and Alberto Cambrosio, “From Screening to Clinical Research: The Cure of Leukemia and the Early Development of the Cooperative Oncology Groups, 1955-1966.” Bulletin of the History of Medicine, 76 (2002), 299-334.

• A31—Peter Keating and Alberto Cambrosio, “The New Genetics and Cancer. The Contributions of Clinical Medicine in the Era of Biomedicine.” Journal of the History of Medicine and Allied Sciences, 56 (2001), 321-352.


• A30—Alberto Cambrosio, “Argumentation, représentation, intervention: les rôles de l'imagerie dans les discours scientifiques.” Asp, 27/30 (2000), 95-112.

• A29—Peter Keating and Alberto Cambrosio, “Biomedical Platforms.” Configurations, 8 (2000), 337-387.

• A28—Alberto Cambrosio and Peter Keating, “Of Lymphocytes and Pixels: The Techno-Visual Production of Cell Populations.” Studies in History and Philosophy of Biological and Biomedical Sciences, 31 (2000), 233-270.

• A27—Peter Keating and Alberto Cambrosio, “Helpers and Suppressors: On Fictional Characters in Immunology.” Journal of the History of Biology, 30 (1997), 381-396.

• A26—Lisa M. Mitchell and Alberto Cambrosio, “The Invisible Topography of Power: Electromagnetic Fields, Bodies and the Environment.” Social Studies of Science, 27 (1997), 221-272.

• A25—Alberto Cambrosio and Peter Keating, “Technique, outil, invention: les transformations d'une biotechnologie.” Sociologie du Travail, 38 (1996), 349-364.

• A24—Camille Limoges, Alberto Cambrosio and Louis Davignon, “Plurality of Worlds, Plurality of Risks.” Risk Analysis, 15 (1995), 699-707.

• A23—Alberto Cambrosio, Peter Keating and Ronald D. Guttmann, “New Medical Technologies and Clinical Practice: A Survey of Lymphocyte Subset Monitoring.” Clinical Transplantation, 8 (1994), 532-540.

• A22—Peter Keating and Alberto Cambrosio, “‘Ours is an Engineering Approach’: Flow Cytometry and the Constitution of Human T-Cell Subsets.” Journal of the History of Biology, 27 (1994), 449-479.

• A21—Alberto Cambrosio, Daniel Jacobi, and Peter Keating, “Ehrlich’s ‘Beautiful Pictures’ and the Controversial Beginnings of Immunological Imagery.” Isis, 84 (1993), 662-699.

• A20—Camille Limoges, Alberto Cambrosio, Frances Anderson, Denyse Pronovost, Dominique Charron, Eric Francoeur, and Eric Hoffman, “Les risques associés au largage dans l’environnement d’organismes génétiquement modifiés: analyse d’une controverse.” Cahiers de recherche sociologique, 21 (1993), 17-52.

• A19—Alberto Cambrosio, Camille Limoges, Jean-Pierre Courtial, and Françoise Laville, “Historical Scientometrics? Mapping Over 70 Years of Biological Safety Research with Co-Word Analysis.” Scientometrics, 27 (1993), 119-143.

• A18—Alberto Cambrosio and Peter Keating, “A Matter of FACS: Constituting Novel Entities in Immunology.” Medical Anthropology Quarterly, 6 (1992), 362-384.

• A17—Alberto Cambrosio and Peter Keating, “Between Fact and Technique: The Beginnings of Hybridoma Technology.” Journal of the History of Biology, 25 (1992), 175-230.

• A16—Alberto Cambrosio and Camille Limoges, “Controversies as Governing Processes in Technology Assessment.” Technology Analysis & Strategic Management, 3 (1991), 377-396.

• A15—Camille Limoges, Alberto Cambrosio, and Denyse Pronovost, “La politique scientifique comme représentation construite en contexte bureaucratique: Le cas de A l’heure des biotechnologies.” Recherches sociographiques, 32 (1991), 69-82.

• A14—Alberto Cambrosio, Peter Keating and Michael Mackenzie, “Scientific Practice in the Courtroom: The Construction of Sociotechnical Identities in a Biotechnology Patent Dispute.” Social Problems, 37 (1990), 275-293.

• A13—Alberto Cambrosio, Camille Limoges, and Denyse Pronovost, “Representing Biotechnology: An Ethnography of Quebec Science Policy.” Social Studies of Science, 20 (1990), 195-227.


• A12—Michael Mackenzie, Peter Keating and Alberto Cambrosio, “Patents and Free Scientific Information in Biotechnology: Making Monoclonal Antibodies Proprietary.” Science, Technology, & Human Values, 15 (1990), 65-83.

• A11—Céline Saint-Pierre and Alberto Cambrosio, “L’autre face de l’informatisation du travail.” Technologies de l’information et société, 2(3) (1990), 79-96.

• A10—Alberto Cambrosio and Peter Keating, “‘Going Monoclonal’: Art, Science and Magic in the Day-to-Day Use of Hybridoma Technology.” Social Problems, 35 (1988), 244-260.

• A9—Michael Mackenzie, Alberto Cambrosio and Peter Keating, “The Commercial Application of a Scientific Discovery: The Case of the Hybridoma Technique.” Research Policy, 17 (1988), 155-170.

• A8—Alberto Cambrosio, Charles H. Davis, and Peter Keating, “Le Québec face aux biotechnologies: bilan et analyse.” Politique, 8 (1985), 77-101.

• A7—Alberto Cambrosio and Peter Keating, “Studying a Biotechnology Research Centre: A Note on Local Socio-Political Issues.” Social Studies of Science, 15 (1985), 723-737.

• A6—Alberto Cambrosio, “The Dominance of Nuclear Physics in Italian Science Policy.” Minerva, 23 (1985), 464-484.

• A5—Alberto Cambrosio, “L’émergence du chercheur scientifique: les syndicats italiens de la recherche après 1945.” Social Science information, 24 (1985), 61-100.

• A4—Alberto Cambrosio and Peter Keating, “The Disciplinary Stake: The Case of Chronobiology.” Social Studies of Science, 13 (1983), 323-353.

• A3—Alberto Cambrosio, “Quando la psicologia entra in fabbrica: selezione e controllo degli operai negli Stati Uniti degli anni ’10.” Testi e contesti, 5 (1980), 43-76 [Italian translation of A2].

• A2—Alberto Cambrosio, “Quand la psychologie fait son entrée à l’usine: sélection et contrôle des ouvriers aux Etats-Unis pendant les années 1910.” Le mouvement social, 113 (1980), 37-65.

• A1—Alberto Cambrosio, “De la lutte contre les nuisances de l’usine à la réappropriation du savoir: quelques expériences italiennes récentes.” Cahiers du socialism, 5 (1980), 28-48.

OTHER ARTICLES

• O11— Alberto Cambrosio and Peter Keating, “Researching the history of recent oncology (Guest Editorial).” Cancerworld,80 (November-December 2017), p. 3.

• O10— Alberto Cambrosio, Peter Keating, Thomas Schlich and George Weisz, “Biomedical Conventions and Regulatory Objectivity: A Few Introductory Remarks.” Social Studies of Science, 39 (2009), 651-664.

• O9—Alberto Cambrosio, “A Personal View (Editorial Comment).” New Genetics and Society, 18 (1999), 7-8.

• O8—Alberto Cambrosio, “Au hasard d’un dimanche, la découverte du château d’Oiron...” La Lettre de l’OCIM, 54 (November-December 1997), 10-11.

• O7—Peter Keating, Miriam Balaban, Alberto Cambrosio and Alfred I. Tauber, “Introduction: Historiographic Issues.” Journal of the History of Biology, 30 (1997), 317-320.

• O6—Alberto Cambrosio, Peter Keating and Alfred I. Tauber, “Introduction: Immunology as a Historical Object.” Journal of the History of Biology, 27 (1994), 375-378.


• O5—Alberto Cambrosio, Camille Limoges, and Denyse Pronovost, “Analysing Science Policymaking: Political Ontology or Ethnography? A Reply to Kleinman.” Social Studies of Science, 21 (1991), 775-781.

• O4—Camille Limoges and Alberto Cambrosio, “Controverses publiques: les limites de l’information.” Biofutur, 100 (April 1991), 87-90.

• O3—Alberto Cambrosio and Peter Keating, “L’étude des rythmes biologiques: notes socio-historiques.” Bulletin du Groupe d’Étude des Rythmes Biologiques, 21(1) (1989), 9-20.

• O2—Alberto Cambrosio, “Des laboratoires aux réseaux socio-techniques: itinéraires d’une sociologie des sciences.” Interface, 9(3) (1988), 22-26.

• O1—Alberto Cambrosio, “Pour une pratique négative de la photographie: un entretien avec David Tomas.” Parachute, 37 (1984-1985), 4-8.

BOOK CHAPTERS

• BC36— Alberto Cambrosio, Étienne Vignola-Gagné, Nicole Nelson, Peter Keating, and Pascale Bourret, “Genomic Platforms and Clinical Research.” In Sahra Gibbon, Barbara Prainsack, Stephen Hilgartner, and Janelle Lamoreaux (Eds), Handbook of Genomics, Health & Society. London: Routledge (forthcoming).

• BC35—Andrew S. Hoffman, Alberto Cambrosio and Renaldo Battista, “Comparative Effectiveness Research in Health Technology Assessment.” In Adrian Levy and Boris Sobolev (Eds), Comparative Effectiveness Research in Health Services. New York: Springer Science + Business Media, 2016; 57-93.

• BC34—Pascale Bourret, Peter Keating and Alberto Cambrosio, “From BRCA to BRCAness: Tales of Translational Research.” In Sahra Gibbon, Galen Joseph, Jessica Mozersky, Andrea zur Nieden and Sonja Palfner (Eds), Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. London: Routledge, 2014; 175-193.

• BC33—Peter Keating and Alberto Cambrosio, “Biomédecine, science et technologie: avancées scientifiques et nouvelles approches conceptuelles.” In Bernardino Fantini (Ed.), Histoire de la pensée médicale contemporaine. Paris: Le Seuil, 2014; 139-155.

• BC32—Alberto Cambrosio, Daniel Jacobi and Peter Keating, “De la figurabilité des concepts immunologiques à leur figement dans les manuels universitaires: principes de textbookisation.” In David Banks (Ed.), L’image dans le texte scientifique. Paris: L’Harmattan, 2013; 153-171.

• BC31—Alberto Cambrosio, Peter Keating and Andrei Mogoutov, “What’s in a Pill? On the Informational Enrichment of Anti-Cancer Drugs.” In Jean-Paul Gaudillière and Volker Hess (Eds), Ways of Regulating Drugs in the 19th and 20th Centuries. Houndmills: Palgrave Macmillan, 2012; 181-205.

• BC30—Peter Keating and Alberto Cambrosio, “Cancer Research and Protocol Patients: From Clinical Material to Committee Advisors.” In: Carsten Timmermann and Elizabeth Toon (Eds), Cancer Patients, Cancer Pathways: Historical and Sociological Perspectives. Houndmills, Basingstoke, Hampshire; New York: Palgrave Macmillan, 2012; 161-185.

• BC29—Alberto Cambrosio, Pascal Cotterau, Stefan Popowycz, Andrei Mogoutov and Tania Vichnevskaia, “Analysis of Heterogenous Networks: The ReseauLu Project.” In:


Claire Brossaud and Bernard Reber (Eds), Digital Cognitive Technologies. Epistemology and Knowledge Society. London: ISTE/Wiley; 2010; 137-152 [English translation of BC24].

• BC28—Alberto Cambrosio, “Standardization Before Biomedicine: On Early Forms of Regulatory Objectivity.” In: Christoph Gradmann and Jonathan Simon (Eds), Evaluating and Standardizing Therapeutic Agents 1890-1950. Basingstoke and New York: Palgrave Macmillan; 2010; 252-261.

• BC28—Alberto Cambrosio, “Introduction: New Forms of Knowledge Production.” In: Paul Atkinson, Peter Glasner and Margaret Lock (Eds), Handbook of Genetics and Society: Mapping the New Genomic Era. London: Routledge, 2009; 465-468.

• BC27—Alberto Cambrosio, Peter Keating, Pascale Bourret, Philippe Mustar and Susan Rogers, “Genomic Platforms and Hybrid Formations.” In: Paul Atkinson, Peter Glasner and Margaret Lock (Eds), Handbook of Genetics and Society: Mapping the New Genomic Era. London: Routledge, 2009; 502-520.

• BC26—Peter Keating and Alberto Cambrosio, “Cancer Clinical Trials: The Emergence and Development of a New Style of Practice.” In: David Cantor (Ed.), Cancer in the Twentieth Century. Baltimore: Johns Hopkins University Press, 2008; 197-223. [reprinted from A45].

• BC25—Alberto Cambrosio, Peter Keating and Pascale Bourret, “Objectivité régulatoire et systèmes de preuves en médecine : Le cas de la cancérologie.” In: Virginie Tournay (Ed.), La gouvernance des innovations biomédicales. Paris: Presses Universitaires de France, 2007; 155-175.

• BC24—Alberto Cambrosio, Pascal Cotterau, Stefan Popowycz, Andrei Mogoutov and Tania Vichnevskaia, “Analyse des réseux hétérogènes: le projet ReseauLu.” In: Claire Brossaud and Bernard Reber (Eds), Humanités numériques. Vol. 1. Paris: Hermès Science, 2007; 165-80.

• BC23—Peter Keating and Alberto Cambrosio, “Le criblage des médicaments: les modèles animaux en recherche thérapeutique au National Cancer Institute (1955-2000).” In Gabriel Gachelin (Ed.), Les organismes modèles dans la recherche médicale. Paris: Presses Universitaires de France, 2006; 181-208.

• BC22—Alberto Cambrosio and Peter Keating, “Cancer Clinical Trials: New Style of Research, New Forms of Risk.” In François Walter, Bernardino Fantini and Pascal Delvaux (Eds), Les cultures du risque (XVIe–XXIe siècle). Geneva: Presses d’Histoire Suisse, 2006; 169-186.

• BC21—Alberto Cambrosio, Daniel Jacobi and Peter Keating, “Arguing with Images: Pauling’s Theory of Antibody Formation.” In: Luc Pauwels (Ed.), Visual Cultures of Science. Rethinking Representational Practices in Knowledge Building and Science Communication. Hanover (NH): Dartmouth College Press/University Press of New England, 2006; pp. 153-194 [reprinted from A37].

• BC20—Andrei Mogoutov, Alberto Cambrosio and Peter Keating, “Making Collaboration Networks Visible.” In Bruno Latour and Peter Weibel (Eds), Making Things Public. Atmospheres of Democracy. Cambridge, MA/Karlsruhe, Germany: MIT Press/ZKM, 2005; 342-345.

• BC19—Peter Keating and Alberto Cambrosio, “Risk on Trial. The Interaction of Innovation and Risk Factors in Clinical Trials.” In: Thomas Schlich and Ulrich Tröhler (Eds), The Risks of Medical Innovation: Risk Perception and Assessment in Historical Context. London: Routledge, 2005; 225-241.

• BC18—Peter Keating and Alberto Cambrosio, “The Production of Biomedical Measures: Three Platforms for Quantifying Cancer Pathology.” In: Gérard Jorland, Annick Opinel and


George Weisz (Eds), Body Counts: Medical Quantification in Historical and Sociological Perspectives. Montreal: McGill-Queen’s University Press, 2005; 173-202.

• BC17—Alberto Cambrosio, “On the Coexistence of Multiple Time Frames in Historical Accounts of Immunology.” In: Anne Marie Moulin and Alberto Cambrosio (Eds), Singular Selves. Historical Issues and Contemporary Debates in Immunology. Paris: Elsevier, 2001; 273-286.

• BC16—Anne Marie Moulin and Alberto Cambrosio, “Introduction: Historical Issues and Contemporary Debates.” In: Anne Marie Moulin and Alberto Cambrosio (Eds), Singular Selves. Historical Issues and Contemporary Debates in Immunology. Paris: Elsevier, 2001; 11-19.

• BC15—Peter Keating and Alberto Cambrosio, “Real Compared to What?: Diagnosing Leukemias and Lymphomas.” In: Margaret Lock, Allan Young and Alberto Cambrosio (Eds), Living and Working with the New Medical Technologies. Intersections of Inquiry. Cambridge: Cambridge University Press, 2000; 103-134.

• BC14—Alberto Cambrosio, Allan Young and Margaret Lock, “Introduction.” In: Margaret Lock, Allan Young and Alberto Cambrosio (Eds), Living and Working with the New Medical Technologies. Intersections of Inquiry. Cambridge: Cambridge University Press, 2000; 1-16.

• BC13—Peter Keating, Camille Limoges, and Alberto Cambrosio, “The Automated Laboratory: The Generation and Replication of Work in Molecular Genetics.” In: Michael Fortun and Everett Mendelsohn (Eds), The Practices of Human Genetics. Dordrecht: Kluwer, 1999; 125-142.

• BC12—Peter Keating and Alberto Cambrosio, “Interlaboratory Life: Regulating Flow Cytometry.” In: Jean-Paul Gaudillière and Ilana Löwy (Eds), The Invisible Industrialist: Manufacturers and the Construction of Scientific Knowledge. London: Macmillan/New York: St. Martin’s Press, 1998; 250-295.

• BC11—Alberto Cambrosio and Peter Keating, “Monoclonal Antibodies: From Local to Extended Networks.” In: Arnold Thackray (Ed.), Private Science: Biotechnology and the Rise of the Molecular Sciences. Philadelphia: University of Pennsylvania Press, 1998; 165-181.

• BC10—Yoshio Nukaga and Alberto Cambrosio, “Medical Pedigrees and the Visual Production of Family Disease in Canadian and Japanese Genetic Counselling Practices.” In: Mary Ann Elston (Ed.), The Sociology of Medical Science and Technology. London: Blackwell, 1997; 29-55.

• BC9—Alberto Cambrosio, “(Re)producing Interdisciplinarity: Social Studies of Medicine at McGill.” In: Liora Salter and Alison Hearn (Eds), Outside the Lines: Issues in Interdisciplinary Research. Montreal: McGill-Queen’s University Press, 1997; 73-78.

• BC8—Alberto Cambrosio, Daniel Jacobi, and Peter Keating, “Image et controverse scientifique dans les premières théories immunologiques.” In: Stéphane Michaud, Jean-Yves Mollier and Nicole Savy (Eds), Usages de l’image au XIXe siècle. Paris: Créaphis, 1992; 166-181.

• BC7—Alberto Cambrosio, Camille Limoges, and Eric Hoffman, “Expertise as a Network: A Case Study of The Controversies Over the Environmental Release of Genetically Engineered Organisms.” In: Nico Stehr and Richard V. Ericson (Eds), The Culture and Power of Knowledge. Inquiries into Contemporary Societies. Berlin: De Gruyter, 1992; 341-361.

• BC6—Peter Keating, Alberto Cambrosio and Michael Mackenzie, “Les outils de la discipline: critères, modèles et mesures dans la controverse affinité/avidité en


immunologie.” In: Adele E. Clarke and Joan H. Fujimura (Eds), La matérialité des sciences. Savoir-faire et instruments dans les sciences de la vie. Le Plessis-Robinson: Synthélabo Groupe - Coll. Les empêcheurs de penser en rond, 1996; 398-450 [French translation of BC5]

• BC5—Peter Keating, Alberto Cambrosio and Michael Mackenzie, “The Tools of the Discipline: Standards, Models and Measures in the Affinity/Avidity Controversy in Immunology.” In: Adele E. Clarke and Joan H. Fujimura (Eds), The Right Tools for the Job: At Work in Twentieth-Century Life Sciences. Princeton: Princeton University Press, 1992; 312-354.

• BC4—Alberto Cambrosio and François Blanchard, “Modélisation, catégorisation et représentation: le cas de l’analyse informatique.” In: Jean-Marie Albertini and Jacques-Henri Jacot (Eds), Nouvelles technologies, nouvelles connaissances. Lyon: Programme Rhône-Alpes - Recherches en Sciences Humaines, 1992; 137-144.

• BC3—Michael Mackenzie, Peter Keating, and Alberto Cambrosio, “Patents, Free Scientific Information and the Changing International Regime in Intellectual Property: The Case of ELISA and Tandem.” In: S. Visalakshi and S. Mohan (Eds), Elisa as Diagnostic Tool: Prospects and Implications. New Delhi: Wiley Eastern, 1992; 123-136.

• BC2—Camille Limoges and Alberto Cambrosio, “La valutazione sociale delle tecnologie: punti di riferimento e prospettive di ricerca.” In: Leonardo Cannavò (Ed.), Studi sociali della tecnologia. Metodologie integrate di valutazione. Roma: Euroma, 1991; 139-170.

• BC1—Pierre Doray and Alberto Cambrosio, “Du robot à l’ordinique, en passant par la bureautique: espaces discursifs, découpages institutionnels.” In: Khadiyatoulah Fall and Georges Vignaux (Eds), L’informatique en perspectives. Québec: Presses de l’Université du Québec, 1989; 73-88.

ENCYCLOPEDIA ARTICLES

• Alberto Cambrosio and Peter Keating, “Biomedical Sciences and Technology: History and Sociology.” In: Neil J. Smelser and Paul B. Baltes (Eds), International Encyclopedia of the Social and Behavioral Sciences. Amsterdam: Pergamon Press, 2001; vol. 2; 1222-1226.

• Peter Keating and Alberto Cambrosio, “Fluorescence-Activated Cell Sorter.” In: Robert Bud and Deborah Jean Warner (Eds), Instruments of Science. A Historical Encyclopedia. New York: Garland, 1998; 247-249.

PROCEEDINGS

• P7 — Oriana Rainho Brás, Jean-Philippe Cointet, João A Nunes, Leonor David and Alberto Cambrosio, “Mapping the networks of cancer research in Portugal: first results.” In Ismael Ràfols, Jordi Molas-Gallart, Elena Castro-Martínez and Richard Woolley (Eds.), Proceedings of the 21ST International Conference on Science and Technology Indicators, Editorial Universitat Politècnica de València, 2016; 406-409.

• P6—Alberto Cambrosio, Peter Keating and Andrei Mogoutov, “Protocols, regimens and substances: The socio-technical space of anti-cancer drugs.” In: Jean-Paul Gaudillière and Volker Hess (Eds.), Ways of Regulating: Therapeutic Agents Between Laboratories,


Plants, Consulting Rooms. Berlin: Max-Planck-Institut für Wissenschaftsgeschichte, Preprint 363, 2008; 175-205.

• P5—Alberto Cambrosio, “Plenary Discussion Comments.” Medicine, Health and Society in Europe. ITEMS Network Symposium, Coimbra: December 15-17, 2004. Coimbra: Centro de Estudos Sociais, 2005; 324-7.

• P4—Camille Limoges, Alberto Cambrosio, Eric Hoffman, Denyse Pronovost, and Dominique Charron, “Biotechnology 1973-1990: What Is There to Be Learned from Public Controversies.” Proceedings of the Workshop on Genetically Modified Fertilizers and Pest Control Agents. Ottawa: Agriculture Canada, 1990; 55-64.

• P3—Camille Limoges, Alberto Cambrosio, Eric Hoffman, Denyse Pronovost, Dominique Charron, Stéphane Castonguay, and Eric Francoeur, “Controversies Over Risks in Biotechnology (1973-1989): A Framework for Analysis.” In: Managing Environmental Risks. Proceedings of an Air & Waste Management Association International Specialty Conference. Pittsburgh: Air & Waste Management Association, 1990; 155-174.

• P2—Peter Keating, Alberto Cambrosio and Michael Mackenzie, “The Role of Laboratory Techniques in the Development of Scientific Concepts: Affinity, Avidity and Monoclonal Antibodies.” In: British Society for the History of Science and the History of Science Society, Program, Papers and Abstracts for the Joint Conference. Manchester, England, 11-15 July 1988. Madison: Omnipress, 1988; 118-125.

• P1—François Blanchard and Alberto Cambrosio, “Disaligning Macro, Meso and Micro Due Process: A Case Study of Office Automation in Quebec Colleges.” In: R.B. Allen (Ed.), Conference on Office Information Systems. New York: ACM Press, 1988; 118-125.

BOOK REVIEWS

• BR16—Review of: Adriana Petryna, When Experiments Travel: Clinical Trials and the Global Search for Human Subjects, Princeton, NJ: Princeton University Press, 2009. In: Isis 101 (2010), pp. 679-680.

• BR16—“Decentering Life.” Review of: Hannah Landecker. Culturing Life. How Cells Became Technologies. Cambridge, MA: Harvard University Press, 2007. In: BioSocieties 4 (2009), pp. 318-321.

• BR15—Review of: Bruno J. Strasser. La fabrique d’une nouvelle science. La biologie moléculaire à l’âge atomique (1945-1964). Florence: Leo S. Olschki Editore, 2006. In: Annals of Science 66 (2009), pp. 426-429.

• BR14—Review of: Steven Epstein. Inclusion: The Politics of Difference in Medical Research. Chicago: University of Chicago Press, 2007. In: Isis 90 (2008), pp. 649-650.

• BR13—Review of: Christian Bonah, Étienne Lepicard and Volker Roelcke, La médecine expérimentale au tribunal. Implications éthiques de quelques procès médicaux au XXe siècle européen. Paris: Éditions des Archives Contemporaines, 2003. In: Bulletin Canadien d’Histoire de la Médecine/Canadian Bulletin of Medical History 22 (2005), pp. 183-184.

• BR12—“So Which Country is Better?” Review of: Arthur A. Daemmrich. Pharmacopolitics: Drug Regulation in the United States and Germany. Chapel Hill: University of North Carolina Press, 2004. In: Chemical Heritage 22(4) (Winter 2004/2005), 40-41.


• BR11—Review of: Thomas Söderqvist, Science as Autobiography. The Troubled Life of Niels Jerne. New Haven: Yale University Press, 2003. In: Journal of the History of Biology 37 (2004), 409-411.

• BR10—Review of: Peter Worsley, Knowledges. Culture, Counterculture, Subculture. New York: The New Press, 1997. In: Transcultural Psychiatry 37 (2000), 280-281.

• BR9—Review of: Soraya de Chadarevian and Harmke Kamminga (Eds), Molecularizing Biology and Medicine. New Practices and Alliances, 1910s–1970s. Amsterdam: Harwood Academic Publishers, 1998. In: Isis 90 (1999), 619-620.

• BR8—Review of: Errol C. Friedberg, Correcting the Blueprint of Life: An Historical Account of the Discovery of DNA Repair Mechanisms. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1997. In: Isis 90 (1999), 844-845.

• BR7—Review of: Ilana Löwy, Between Bench and Bedside. Science, Healing, and Interleukin-2 in a Cancer Ward. Cambridge, MA: Harvard University Press, 1996. In: History and Philosophy of the Life Sciences 20 (1999), 844-845.

• BR6—Review of: Joan H. Fujimura, Crafting Science: A Sociohistory of the Quest for the Genetics of Cancer. Cambridge, MA: Harvard University Press, 1996; Myer H. Salaman, Experiment and Interpretation. A Pathologist Reflects on Thirty Years of Cancer Research. London: Athlone, 1995. In: Social History of Medicine 11 (1998), 344-345.

• BR5—Review of: Brian S. Baigrie (Ed.), Picturing Knowledge. Historical and Philosophical Problems Concerning the Use of Art in Science. Toronto: University of Toronto Press, 1996. In: The Canadian Review of Sociology and Anthropology 34 (1997), 434-436.

• BR4—Review of: Nicolas Dodier, L’expertise médicale. Paris: Métailié, 1993. In: Contemporary Sociology 23 (1994), 890-891.

• BR3—Review of: Bruno Latour, Nous n’avons jamais été modernes. Essai d’anthropologie symétrique. Paris: Éditions La Découverte, 1991; Bruno Latour, Aramis, ou l’amour des techniques. Paris: Éditions La Découverte, 1992. In: Contemporary Sociology 22 (1993), 485-487

• BR2—Review of: Bruno Latour, La science en action. Paris: La Découverte, 1989. In: Canadian Journal of Sociology 15 (1990), 501-504.

• BR1—Review of: Gianni Micheli (Ed.), Storia d’Italia. Scienza et tecnica nella culture e nelle società dal Rinascimento a oggi. Turin: Einaudi, 1980. In: Isis 73 (1982), 281-282.

MEDIA INTERVIEWS

• Entretien avec Alberto Cambrosio, professeur invité, au sujet de son livre “Cancer on trial, Oncology as a New Style of Practice”, CSO - SciencesPo website, 20 June 2012, http://www.cso.edu/fiche_actu.asp?actu_id=1150.

• Pei Koay and Michal Meyer, Personalized Medicine Here and Now (Interview with Alberto Cambrosio), Chemical Heritage 28(1) (Spring 2010), 11.

• Bruno Lamolet, Le discours parallèle de l’image (Entrevue avec Alberto Cambrosio), Découvrir 30(3) (May 2009), 32-35.

• Jean-Paul Gaudillière, Interview with Alberto Cambrosio, Les Cahiers de Science et Vie, no. 35 (October 1996), 94-95.


Communications and abstracts

SCIENTIFIC MEETINGS (>2010)

• Alberto Cambrosio, “Testing a strategy and/or testing drugs? Apropos the new generation of cancer clinical trials”, STS-Italia and BIOM (Società Italiana di Storia, Filosofia e Studi Sociali della Biologia e della Medicina) Workshop "La cura del cancro e l’innovazione tenologica: Aspetti etico-sociali”, Rovigo (taly), 13-14 April 2018.

• Alberto Cambrosio, Peter Keating, Pascale Bourret, Étienne Vignola-Gagné, Jonah Campbell, and Bertrand Jordan, “Overcoming the bottleneck”: Knowledge architectures for genomic data interpretation in the field of oncology, Conference on “Varieties of Data Journeys”, University of Exeter, 2-3 November 2017.

• Pascale Bourret and Alberto Cambrosio, Molecular Tumor Boards as collective expertise: Bio clinical decision-making in cancer genomics. Session on “Promissory technologies, disciplinary boundaries, and the reconfiguration of expertise: Cancer in the 21st century”, 4S Annual Meeting, Boston, 30 August – 2 September 2017.

• Patrick Castel, Pascale Bourret, Alberto Cambrosio, and Henri Bergeron, Organizing and experimenting: Genomic clinical trials as epistemic and organizational innovation. Session on “Experimenting Organization: Becoming by Doing”, 33rd EGOS Colloquium, Copenhagen, Denmark, July 6–8, 2017.

• Jean-Philippe Cointet, Alberto Cambrosio, and Pascale Bourret, Oncology's metaknowledge networks: an investigation of the collective dynamics of bio-clinical innovation, Workshop “Exploring technoscience through digital platforms and computational tools. The emergence of new methodological perspectives in S&TS”, PaSTIS (Padua Science, Technology, Innovation Studies), Università di Padova (Italy), 2-3 May 2017

• Alberto Cambrosio, Peter Keating, Pascale Bourret, Étienne Vignola-Gagné, and Bertrand Jordan, Knowledge architectures for genomic data interpretation in the field of oncology, Workshop “Data Journeys in Biomedicine: Data Use, Research Translation and the Management of Infrastructures”, University of Exeter, 11-13 January 2017.

• Oriana Rainho Brás, Jean-Philippe Cointet João Arriscado Nunes, Leonor David, and Alberto Cambrosio, Mapping the networks of cancer research in Portugal (1990-2015): first results, STI2016 - 21st International Conference on Science and Technology Indicators, València (Spain), 14-16 September 2016.

• Alexandre Abdo, Jean-Philippe Cointet and Alberto Cambrosio, Oncology research: Looking for the core-set, Joint meeting of the Society for Social Studies of Science (4S) and the European Association for the Study of Science and Technology (EASST), Barcelona (Spain), August 31-September 3, 2016.

• Alberto Cambrosio, Pascale Bourret, Peter Keating and Sylvain Besle, Molecular Tumor Boards: Data interpretation in the age of sequencing, Joint meeting of the Society for Social Studies of Science (4S) and the European Association for the Study of Science and Technology (EASST), Barcelona (Spain), August 31-September 3, 2016.

• Etienne Vignola-Gagné, Peter Keating and Alberto Cambrosio, Les médicaments comme nouveaux instruments de production des connaissances en cancérologie, 84e congrès


de l’ACFAS (colloque 604: Pratiques et enjeux de l'expérimentation en santé et dans le champ social), UQAM, Montreal, May 9-13, 2016.

• Etienne Vignola-Gagné, Alberto Cambrosio and Peter Keating, Experimental Design and Organizational Change in Genomic-Driven Cancer Clinical Research, Annual meeting of the American Society for the History of Medicine, Minneapolis, MN April 28-May 1, 2016.

• Alberto Cambrosio, Mapping the development of Portuguese clinical research in oncology, 2nd ASPIC (Portuguese Association for Cancer Research) International Congress, Porto, April 28-29, 2016 [invited ASPIC lecture].

• Alberto Cambrosio, Associating research and care: The example of oncology”, Workshop on “Genomics as a health care strategy: Persons, practices, policies, Institut Curie, Paris, April 14-15, 2016.

• Etienne Vignola-Gagné, Peter Keating and Alberto Cambrosio, Reductionism and complexity in oncology: pathways, drivers, passengers, and checkpoints, Annual Meeting of the Society for Social Studies of Science (4S), Denver (CO), November 11-14, 2015.

• Pascale Bourret, Alberto Cambrosio, Peter Keating and Etienne Vignola-Gagné, Singularization in the cancer clinic: genomics, targeted therapies and emerging diagnostic entities and configurations, ISHPSSB 2015 Conference, UQAM, Montreal, 5-10 July 2015.

• Etienne Vignola-Gagné, Alberto Cambrosio, Peter Keating, From informed to informing materials: drugs as tools for exploring cancer mechanisms and pathways, ISHPSSB 2015 Conference, UQAM, Montreal, 5-10 July 2015.

• Alberto Cambrosio, Big Data in Biomedicine, European Research Council’s DATA_SCIENCE Exploratory Workshop “What Is Data-Intensive Science?”, Exeter Centre for the Study of the Life Sciences, University of Exeter, 17-19 December 2014.

• Alberto Cambrosio, Peter Keating, Nicole Nelson and Pascale Bourret, Reassembling The Cancer Clinic: Genomics, ‘Actionability' and Emerging Diagnostic Configurations, XVIII ISA World Congress of Sociology, Yokohama, Japan (July 13-19, 2014).

• Pascale Bourret and Alberto Cambrosio, Reassembling the cancer clinic: from personalization to singularization, Workshop “Getting Personal: Technologies of Personalization in Evidence-Based Medicine,” Linköping University/University of Göteborg, Vadstena Klosterhotell, 6-9 May 2014.

• Peter Keating, Alberto Cambrosio and Nicole Nelson, Molecular oncology’s hybrid entities and the redefinition of risk: the case of Triple-Negative Breast Cancer, Session “Managing Risk and Uncertainty in Postwar Biomedicine,” History of Science Society’s 2013 meeting, Boston (MA), 21-24 November 2013.

• Nicole Nelson, Peter Keating Alberto Cambrosio, Adriana Aguilar-Mahecha, and Mark Basik, Testing devices or experimental systems? Cancer clinical trials take the genomic turn, 2013 Canadian Cancer Research Conference, Toronto, 3-6 November 2013 [poster presentation].

• Alberto Cambrosio (in collaboration with Peter Keating and Nicole Nelson), From Risk to Actionability. Notes on the Emerging Contours of a Regime of Genomic Medicine in Oncology, La Nanomédecine: Enjeux philosophiques, Paris. Université Paris 1, Centre Panthéon, 17‐18 October 2013 (keynote address).

• Nicole Nelson, Peter Keating, and Alberto Cambrosio, On Being “Actionable”: Clinical Sequencing and the Emerging Contours of a Regime of Genomic Medicine in Oncology, Annual Meeting of the Society for Social Studies of Science (4S), San Diego (CA), October 9-12, 2013.


• Alberto Cambrosio, Un déluge de données? Regards croisés (et réflexifs) sur le défi des grands nombres entre biomédecine et sciences sociales, Rifreq 2013: 4ème Congrès du Réseau international francophone de la recherche qualitative, Fribourg (Switzerland), 19-21 June 2013 (invited keynote speaker).

• Alberto Cambrosio, Big data, translational research and the reshaping of oncology in the post-genomic era, STS Italia Workshop, PaSTIS (Padua Science, Technology, Innovation Studies), Università di Padova (Italy), 19 April 2013.

• Pascale Bourret and Alberto Cambrosio, BRCAness: Redefining BRCA genes in the era of post-genomic medicine, 4S/EASST 2012 Conference, Copenhagen (Denmark), October 17-20, 2012.

• Pascale Bourret and Alberto Cambrosio, A roadmap to personalized oncology? The trials and tribulations of breast cancer biomarkers, International Conference “Towards personalized medicine? Biomarkers between health care practices and imagined futures”, University of Vienna, June 28-29, 2012.

• Alberto Cambrosio, La recherché translationelle et l’évolution des essais cliniques en cancérologie: nouvelles molécules, nouvelles cibles, nouveaux assemblages, Journée de travail “Les essais précoces en cancérologie : quelles définitions, quelle justice ?”, Collège de France, Paris, 24 May 2012.

• Peter Keating, Nicole Nelson, and Alberto Cambrosio, Two views of genomics in action, The 3rd Quebec Conference on Therapeutic Resistance in Cancer, Montreal, March 15-17, 2012.

• Alberto Cambrosio, Peter Keating, Pascale Bourret, Nina Kohli-Laven, and Nicole Nelson, Personalized, stratified, targeted, individualized or precision medicine? Disruptive technologies and the reassembling of oncology, SMEC (Studies on Medicine, Expertise and Controversy) workshop on “Optimising Health Care: Evidence-based medicine, person-centred care and new technologies as mediators”, Gothenburg, 18-20 April 2012

• Alberto Cambrosio, Consortiums, technologies de rupture et plateformes hybrides: une nouvelle configuration de la recherche à l’interface génomique et cancer, Deuxième Colloque Génopole-IFRIS, Paris, December 8, 2011.

• Pascale Bourret and Alberto Cambrosio, From BRCA to BRCAness. Redefining the clinical utility of BRCA genes in the era of personalized medicine and targeted therapy, Workshop “BRCA Gene Research and Medical Practices: A comparative transnational social science workshop”, Brocher Foundation, Geneva, December 5-7, 2011.

• Nicole Nelson, Peter Keating and Alberto Cambrosio, Practices, Platforms and Promises in Genomic Medicine, Annual Meeting of the Society for Social Studies of Science (4S), Cleveland, Ohio, November 2-5, 2011.

• Alberto Cambrosio, Comment analyser la “génomique en action”? Quelques pistes de recherche et d’analyse, Colloque pluridisciplinaire “Perspectives philosophiques sur la médecine personnalisée : un nouvel agencement de technologies scientifiques, de clinique et de valeurs”, projet ANR nano2e (Paris, 21-22 October 2011).

• Pascale Bourret, Alberto Cambrosio, Nina Kohli-Laven, and Peter Keating, A roadmap to personalized oncology? The trials and tribulations of breast cancer biomarkers, Workshop “Biomarkers in Practice: Unpacking Pasts, Presents and Futures”, Brocher Foundation, Geneva, June 6-7, 2011.

• Peter Keating, Alberto Cambrosio, Pascale Bourret, and Nina Kohli-Laven, Samples, Evidence, Data, Utility: Biobanks and Databanks in Clinical Oncology, International conference on “Making Sense of Large Datasets: Perspectives Across the Sciences”, ESRC Centre for Genomics in Society (Egenis), University of Exeter, June 20-21, 2011.


• Nina Kohli-Laven, Alberto Cambrosio, Peter Keating, Nicole Nelson and Pascale Bourret, Cancer Itself? Redefining Patients and their Diseases in Postgenomic Oncology, Conference on “Biopower Today”, Zurich, June 9-11, 2011.

• Alberto Cambrosio, La recherche translationnelle et le cadrage scientifique et réglementaire des signatures génomiques pour le cancer du sein, Workshop “Innovation, génomique et recherche clinique en cancérologie :Enjeux de Sciences Humaines, Economiques et Sociales”, Canceropôle PACA, Marseille, April 8, 2011.

TALKS AND INVITED LECTURES (>2010)

• Big data in oncology, Shoptalk, McGill University, 14 March 2017. • Reassembling the cancer clinic: on the co-production of epistemic and organizational

innovation in translational cancer research, Department of Science, Technology and Innovation Studies, and Usher Institute of Population Health Sciences and Informatics, University of Edinburgh (UK), 16 December 2015.

• Taming big data in biomedicine: the case of oncology, Data Discussion Group, University of Wisconsin, Madison, 24 September 2015.

• On the co-production of epistemic and organizational innovation: translational research in oncology, Robert F. & Jean E. Holtz Center for Science & Technology Studies, University of Wisconsin, Madison, 24 September 2015.

• Reassembling the cancer clinic: translational research, actionable mutations, and the reframing of cancer clinical trials, Invited lecture, Oncology Institute (Lisbon, Portugal), 12 May 2015.

• Genomic medicine enters the clinic: translational research, actionable mutations, and the reframing of cancer clinical trials, Keynote Speaker, Medical oncology Training Program, University of Ottawa, Residents’ Annual Retreat, 15 May 2014.

• Reassembling the cancer clinic: genomics, ‘actionability’ and emerging configurations of biomedical practice, Kaspar Naegele Memorial Lecture, Department of Sociology, University of British Columbia, 1 April 2014.

• When drugs cross disease lines. (Dis)assembling clinical research in post-genomic oncology, STS Circle, Harvard University, 24 March 2014.

• Biomedical standards, norms and conventions, Master of Public Affairs, Sciences Po (IEP), Paris, 22 April 2013.

• Genomics enters the cancer clinic: a report from the translational research arena, Department of Science & Technology Studies, Cornell University, 4 March 2013.

• À propos du livre Cancer On Trial, Centre de Sociologie des Innovations (CSI), École des Mines de Paris – ParisTech, 14 June 2012.

• La biomédecine à l’épreuve de la génomique : reconfigurer l’oncologie, Centre de Sociologie des Organisations, Sciences Po, Paris, 15 May 2012.

• Investigating the collective turn in oncology and cancer research: A few methodological and conceptual issues, Seminar series “Approches et méthodes, sciences, technologies, santé et sociétés (ST2S)”, Laboratoire d'Epistémologie des Sciences de la Vie et de la Santé, Institut de recherches interdisciplinaires sur les sciences et la technologie (IRIST-LESVS), Université de Strasbourg, 5 April 2012.

• Biomedical standards, norms and conventions, Master of Public Affairs, Sciences Po (IEP), Paris, 27 March 2012.


• Génomique et cancer: consortiums, technologies de rupture, et plateformes hybrides, Institut Francilien Recherche Innovation et Société (IFRIS), Université Paris-Est, Marne-la-Vallée, 2 April 2012.

• Hybrid platforms, disruptive technologies and the reassembling of oncology, Campus IFOM-IEO (Fondazione Istituto di Oncologia Molecolare - Istituto Europeo di Oncologia), Milano, 25 January 2012.

• Biomedical standards, norms and conventions, Master of Public Affairs, Sciences Po (IEP), Paris, 12 April 2011.

SUPERVISION OF POST-DOCTORAL FELLOWS

• 2016-2017: Étienne Vignola-Gagné, “Organizational change as experimental practice in contemporary innovation systems” (Ph.D. University of Vienna; SSHRC Postdoctoral Fellowship; student number: 260609150).

• 2014-2016: Étienne Vignola-Gagné, “Practices and Emerging Socio-Technical Configurations in Translational Research: The Case of Early-Phase Clinical Trials in Oncology” (Ph.D. University of Vienna; FRQSC Postdoctoral Fellowship; student number: 260609150).

• 2011-2013: Nicole Nelson, “Cancer Genomics and Biomarker-Driven Clinical Trials in Oncology” (Ph.D. Cornell University; Genome Quebec grant stipend; student number: 260129138).

• 2011-2013: Christopher Canning, “Human Genetics and the Epigenetics of Mental Health” (Ph.D. Queen’s University; SSHRC Postdoctoral Fellowship; student number: 260398290).

• 2009-2011: (in collaboration with George Weisz and Andrea Tone) Christopher Canning, “Medical Genetics at McGill” (Ph.D. Queen’s University; Dr. Tone’s CRC grant; student number: 260398290).

• 2009-2012: Nina Kohli Laven, “Translational Cancer Research” (Ph.D. University of Michigan, Ann Arbor; CIHR grant stipend; student number: 260389821).

• 2002-2005: Pierre Pluye, “Implantation des aides électroniques à la prise de décision en médecine familiale” (Ph.D. University of Montreal, CIHR Postdoctoral Fellowship; student number: 119751996).

• 2000-2002: Kenton Kroker, “Epidemic encephalitis in North America, 1919-1939” (Ph.D. University of Toronto; SSHRC Postdoctoral Fellowship; student number: 110050435).

• 2000-2002: Eve Seguin “Human BSE. The production of a political crisis by prion proteins” (Ph.D. University College London; SSHRC Postdoctoral Fellowship; student number: 110050782).

• 2001: Janine Barbot “Les recours en justice des victimes d’accidents médicaux. Une sociologie des formes de contestation publique autour de la médecine contemporaine” (Ph.D. École des Hautes Études en Sciences Sociales, Paris; INSERM Postdoctoral Fellowship; student number: 110145468).


SUPERVISION OF GRADUATE STUDENTS

HONOURS THESIS (COMPLETED) • Stefan Popowycz, Impact Factor: A Scientometric Analysis of Graduate Students

(Sociology, McGill; December 2002; student number: 9631106). • Evan Voroney, Controversy and New Biotechnologies: The Case of the HIV Rapid Test

(Sociology, McGill; April 2006; student number: 110124603) M.A. (COMPLETED) • Zlatko Anguelov, Positron Emission Tomography in the Montreal Neurological Institute &

Hospital: A Case Study of a Frontier Technology (M.A., Medical Sociology - McGill; 09/1993 - 06/1995).

• Yoshio Nukaga, A Visual Transcription of ‘Family Disease’: A Comparison of the Use of Medical Pedigrees in Genetic Counseling Practices in Canada and Japan (M.A., Medical Sociology - McGill; 09/1993 - 02/1996; student number: 9353674).

• Marian P. Smith, MOCOMP: A System of Continuing Medical Education for Physicians and its Role in Maintaining Professional Jurisdiction (M.A., Sociology - McGill; 09/1995 - 11/1997; student number: 9546792).

• Andrew Scyner, Family and Community Medicine in Costa Rica: Where Professionalization Meets Development (M.A., Medical Sociology - McGill; 09/1993 - 06/1997; student number: 8817135).

• Louise Granofsky, The dental amalgam controversy in Canada: A sociological analysis (M.A., Medical Sociology - McGill; 01/1995 - 09/1998; student number: 9548286).

• Martha Poon, Of Molecules and Networks: Tracing the Connections Between the Distribution of Samples, the Production of Genetics Maps and the Valuation of DNA in Human Genetics Research (M.A., Medical Sociology - McGill; 09/1999 - 09/2001; student number: 9426414).

• Stefan Popowycz, Classifying Migraines: The International Headache Society and the Production of the International Headache Classification System (Medical Sociology - McGill; 01/2003 – 05/2005; student number: 9631106).

• Yannick Fortin, Deploying Pharmacogenomics Through Multiple Communities of Practice (M.A., Medical Sociology - McGill; 09/2006 – 01/2008; student number: 260217772).

• Nicole Mardis, The State of Health Information Technology Standards: The conflation of the Technical and the Political in the Development of a Pan-Canadian Electronic Health Record System (M.A., Medical Sociology - McGill; 09/2007 – 10/2009; student number: 260270597).

• Jonah D. Campbell, The XMRV Virus: Reality and Artefactuality in Scientific Controversy (M.A., Medical Sociology – McGill; 09/2010 – 04/2012; student number: 260419908).

M.A. (ONGOING) PH.D. (COMPLETED) • Louise J. Caron, Étude de construction de systèmes administratifs informatisés dans un

Ministère (Ph.D., Sociology - UQAM; co-supervision with Céline Saint-Pierre 01/1987 – 09-1996; 09/1997-06/1998).


• Eric Francoeur, The Forgotten Tool: A Socio-historical Analysis of the Development and Use of Mechanical Molecular Models in Chemistry and Allied Disciplines (Ph.D., Sociology - McGill; 09/1992 - 06/1998; student number: 8611472).

• Yoshio Nukaga, A Genealogy of Genealogical Practices: The Development and Use of Medical Pedigrees in the Case of Huntington’s Disease (Ph.D., Sociology - McGill; 09/1995 - 10/2000; student number: 9353674).

• Annalisa Salonius, Working in the Lab: Examining the Social Organization of Research in the Biomedical Sciences through the Work Histories of Graduate Students and Postdocs (Ph.D. Sociology - McGill; 09/1996 [supervisor switch in 2002] – 11/2007; student number: 118112611).

• Susan Rogers, Social Arrangements in Genomic Science: How Microarray Data and Scientists Shaped Each Other (Ph.D. Sociology - McGill; 09/2004 – 10/2011; student number: 260148160).

• Loes Knaapen, In Search of Standards that Avoid Standardization: The Production and Regulation of Evidence Based Guidelines (Ph.D. Sociology - McGill; 09/2006 – 02/2013; student number: 110037919).

PH.D. (ONGOING) • Andrew Hoffman, Prioritizing Precision: Engagements with Value in Cancer Genomic

Clinical Trials (Ph.D. Sociology - McGill; 09/2007 - present; student number: 260215332) • Stephanie Nairn, Enacting Tensions and Contemplating Pleasures: The Everyday

Experience of Food Allergy (Ph.D. Sociology - McGill; 09/2012 - present; student number: 260366188).

• Aharon Blank-Gomel, Conquering the Accidental: Traffic Risks as Networks of Expertise (Ph.D. Sociology - McGill; 09/2011 - present; student number: 260466868).

• Elise Karagueuzian, title TBA (Ph.D. Sociology – McGill; 09/2014 - present; student number: 260598291).

THESIS COMMITTEE MEMBER M.A. (COMPLETED) • Janalyn Prest, O’ the tangled webs we weave, when first we practice to

conceive: navigating the online commodification, distribution, and consumption of donor sperm (M.A. Medical Anthropology – McGill, 2000).

• Steven Neil Cohen, Eye Movement Desensitization and Reprocessing (EMDR): The Making of a Psychotherapy (M.A. Medical Anthropology – McGill, 2000).

PH.D. (COMPLETED) • Melanie Rock, Sweet blood and power: making diabetics count (Ph.D. Medical

Anthropology – McGill, 2001). • Jennifer Cuffe, An empirical study of scientists’ reasoning in the Canadian regulatory

evaluation of traditional, homeopathic, herbal and other ‘natural’ medicines (Ph.D. Medical Anthropology – McGill, 2011).

• Hadi Karsoho, Physician-Assisted Dying and The Politics of End-of-Life Care (Ph.D. Sociology – McGill, 2016).

PH.D. (ONGOING)


MEMBER OF PH.D. QUALIFYING EXAM • Zhumping (Juian) Xue, Department of Biology (McGill), 1 March 2010. EXTERNAL (McGILL) THESIS EXAMINER • Nahid Tabatabaei, Contribution of Information Science to Other Disciplines As Reflected in

Citation Context of JASIST Highly Cited Papers (Ph.D. Thesis, School of Information Studies, McGill University), 4 April 2013.

• Jennifer Cuffe, Configuring Commensurability: An Ethnography of the Evaluation of Herbal Medicines in Canada (Ph.D. Thesis, Department of Anthropology, McGill University) 10 February 2011.

• Vincent Larivière, A Bibliometric Analysis of Quebec PhD Students’ Contributions to the Advancement of Knowledge (Ph.D. Thesis, School of Information Studies, McGill University), 21 April 2010.

• Junko Kitanaka, Society in Distress: The Psychiatric Production of Depression in Contemporary Japan (Ph.D. Thesis, Department of Anthropology, McGill University), 1 May 2006.

EXTERNAL THESIS EXAMINER • Louis Braverman, La fabrique du sujet vulnérable : étude sur l’expérience du cancer de la

prostate (Ph.D. Thesis, École des Hautes Études en Sciences Sociales, Paris), 19 June 2017.

• Sylvain Besle, Étude des structures de coordination entre soins et recherche. Le cas des essais précoces en cancérologie (Ph.D. Thesis, Paris-Sorbonne Université), 8 December 2015.

• Audrey Vézian, Le Plan Cancer 2003-2007: entre échec d’une réforme et “re-enchantement mythique” de l’action publique (Ph.D. Thesis, Sciences Po, Paris), 17 June 2013.

• Bryn Lander, Mapping interorganisational collaboration within infection and immunity research (Ph.D. Thesis, Interdisciplinary Studies, University of British Columbia), June 2013.

• Daniel Navon, Genomic Designation: New kinds of people at the intersection of genetics, medicine and social action (Ph.D. Thesis, Department of Sociology, Columbia University), 13 May 2013.

• Vololona Rabeharisoa, La co-production des savoirs, des causes et des collectives. Quelques examples dans le domaine de la biomédecine (Habilitation Thesis, Université de Rennes), 24 September 2007.

• Virginie Tournay, Produire des biens publics médicaux: contribution pragmatique à une sociologie de l’action publique (Ph.D. Thesis, Science-Politique, Université de Paris I-Sorbonne), 19 January 2005.

• Martin Rémondet, Le laboratoire de thérapie génique à l’épreuve de la clinique: sociologie d’une expérimentation biomédicale (Ph.D. Thesis, Socio-économie de l’innovation, École des Mines de Paris), 13 December 2004.

• Sophie Houdart, Et le scientifique tint le monde. Ethnologie d'un laboratoire japonais de génétique du comportement (Ph.D. Thesis, Ethnologie et sociologie comparée, Université de Paris XI-Nanterre), 6 May 2000.


OTHER ACTIVITIES

COMMITTEES AND ADVISORY BOARDS • Fall 2016: Chair of the Review Committee for McGill University’s Department of

Languages, Literatures & Cultures (Faculty of Arts). • 2016-2017: Member of the External Scientific Advisory Board of LYRic (Lyon Research

Innovation for Cancer). • 2016: Member of the Jury of the competition “La preuve par l'image 2016”, jointly

organized by ACFAS and NSERC. • 2015-2020: Inaugural Member of the College of Reviewers of the Canadian Institutes of

Health Research (CIHR). • 2015-2020: Member of the Project Advisory Group of the Wellcome Trust Senior

Investigator Award in Medical Humanities Project “Translations and transformations in patienthood: cancer in the post-genomics era” (PIs: Anne Kerr, University of Leeds, and Sarah Cunningham-Burley, University of Edinburgh).

• 2014-2019: Member of the Advisory Board of the European Research Council’s Project “The Epistemology of Data-Intensive Science (DATASCIENCE)” (PI: Sabina Leonelli, University of Exeter).

• 2013-2014: Member of the “Ad hoc Committee on the modernization of the Thematic Research Networks Program” of Quebec’s Fonds de la recherche en Santé.

• 2012-2015: Member of the University Tenure Committee of the faculty of Law, McGill University.

• 2009: Member of the Expert Committee established by the Agence française d’évaluation de la recherche et de l’enseignement supérieur (AERES) to evaluate two French research centers (CERMES and CESAMES, Paris).

• 2007–2009: member of the Advisory Committee GE3LS (Genomics, Ethic, Economics, Environment, Law and Society) of Génome Québec.

• 1998-99: Chair, Nicholas C. Mullins Award (Student Paper Prize) Committee, Society for Social Studies of Science (4S).

GRANTS: PANEL MEMBER • 2016: Member of the pool of reviewers for the Stage 1 of the Canadian Institutes of Health

Research (CIHR) Project Scheme 1st Live Pilot competition. • 2015: Member of the Scientific Evaluation Committee of the Institut National du Cancer

(INCa - France), for the mid-term évaluation of the SIRIC (Integrated Cancer Research Sites) program.

• 2014: Member of the peer review committees of the Canadian Institutes of Health Research (CIHR) Open Operating Grant Programs: Humanities, Social Sciences, Law & Ethics in Health (HLE) and Ethics Catalyst Grant (EPP).

• 2014: Member of the Scientific Evaluation Committee of the Institut National du Cancer (INCa - France) for the program ‟Designation of Canceropoles 2015-2017”.

• 2011-2013: Member of the Evaluation Committee of the “Programme Sociétés Innovantes” of the French Agence Nationale de la recherche (ANR).

• 2011-2012: Member of the Evaluation Committee of the Institut National du Cancer (INCa - France) for the program ‟Sites de recherche intégrée sur le cancer (SIRIC)”.


• 2011: Member of the Evaluation Committee of the Institut National du Cancer (INCa - France) for the program ‟Constitution de bases clinicobiologiques multicentriques à visée nationale en cancérologie”.

• 2003-2004: Member of the Selection Committee of the “Programme d’établissement de nouveaux professeurs-chercheurs,” Fonds québécois de recherché sur la société et la culture (FQRSC)

• 1992-1994: Member of the Selection Committee for the Eco-Research Program, Tri-Council Secretariat (S.S.H.R.C., N.S.E.R.C., M.R.C.).

JOURNALS: EDITORIAL BOARD 2008-present: Member of the Editorial Board of Medicine Studies. 2007-present: Member of the Editorial Board of History and Philosophy of the Life Sciences. 2007-present: Member of the Scientific Board of Rivista per le Medical Humanities. 2005-present: Member of the Editorial Advisory Board of Social Studies of Science. 1998-present: Member of the International Editorial Advisory Board of New Genetics and Society. 1996-1999: Member of the Advisory Editorial Board of Social Problems. CONFERENCE AND SESSION ORGANIZER • Member of the scientific committee of the Conference “Social Sciences and Humanities

Research: translating findings into medical practices”, Marseille, France, October 12-13, 2017.

• Member of the international scientific committee of the Colloquium “Patients in the healthcare ecosystem: Information challenges and communication issues”, Institut des sciences de la communication du CNRS, Paris, December 1-2, 2014.

• Co-organizer (with Peter Keating): Open panel session on “Clinical Research in Post-Genomic Medicine”, 4S/EASST 2012 Conference, Copenhagen (Denmark), October 17-20, 2012.

• Co-organizer (with Joan Fujimura and Pascale Bourret): Session on “Post-genomic medicine: redesigning and reframing the socio-technical fabric,” 4S Annual Meeting, Tokyo (jointly with the Japanese Society for Science and Technology Studies), August 25-29, 2010.

• Organizer: 2010 Gordon Cain Conference - Personalized medicine here and now: Empirical studies of post-genomic medicine. Chemical Heritage Foundation, Philadelphia, May 6-7, 2010.

• Co-organizer (with Teun Zuiderent-Jerak): Session on “Tinkering with Objectivity: The Production of Guidelines and their Consequences,” 4S Annual Meeting, Washington, DC, October 28 – November 1, 2009.

• Co-organizer (with Miguel Garcia-Sancho and Joan Fujimura): Session on “Governing and Institutionalizing Genomics: An Interdisciplinary and Interorganizational Perspective,” 4S/EASST Joint Meeting, Rotterdam, 20-23 August 2008.

• Organizer: Session on “Taming Microarrays,” 3rd International Workshop on “Genetics, History and Public Understanding”, Barcelona, 30-31 May 2008.

• Co-organizer (with Peter Keating, Thomas Schlich and George Weisz): Workshop on “The Institutions of Objectivity in Medicine: Informal and Formal Modalities of Regulation,” McGill University, April 19-21, 2007.


• Co-organizer (with Peter Keating): Session on “New Regimes of Evidence in Biomedicine: Staging Proofs, Managing Data,” Annual Meeting of 4S (Society for Social Studies of Science), Vancouver (BC), November 2 - 4, 2006.

• Co-organizer (with Anne Marie Moulin): Conference on “Immunology: Historical Issues and Contemporary Debates,” Musée Claude Bernard, Saint-Julien-en-Beaujolais (France), 4-6 June 1998, sponsored by the Marcel Mérieux Foundation.

• Organizer: Session on “Ethnographies of Visual Practices,” Joint International Meeting of 4S (Society for Social Studies of Science) and EASST (European Association for the Study of Science and Technology), University of Bielefeld (Germany), October 10-13, 1996.

• Co-organizer (with Allan Young and Margaret Lock): Conference on “The Cultures of Biomedical Technologies,” Cambridge (UK), July 3-5, 1996, sponsored by the Social Sciences Research Council and the Wenner-Gren Foundation.

• Section Head (Anthropology - Sociology), 64th Meeting of the ACFAS, McGill University, Montreal, May 1996.

• Co-organizer (with Jean Paul Gaudillière and Thomas Söderqvist): Session on “Post-World War II Biomedicine,” Meeting of the International Society for the History, Philosophy and Social Studies of Biology,” Leuven (Belgium), July 19-23, 1995.

• Co-organizer (with Miriam Balabam and Peter Keating): Conference on “Conceptual Issues at the Interface between Immunology and Epidemiology,” cosponsored by the Boston Colloquium for the Philosophy of Science and the Consorzio Mario Negri Sud, Santa Maria Imbaro (Italy), May 25-28, 1995.

• Co-organizer (with Alfred I. Tauber and Peter Keating): Colloquium on “Conceptual Issues in Immunology: Experimental and Clinical Foundations,” sponsored by the Boston Colloquium for the Philosophy of Science, Boston University, May 5-6, 1993.

• Co-organizer (with Camille Limoges): International Conference “Biotechnology and the Environment: Managing the Risks,” Montreal, November 15-16, 1990.

• Member of the Program Committee of the Fourteenth Annual Meeting of the Society for Social Studies of Science (Irvine, California, November 15-18, 1989).